TapewireFind a company

person · Reporting owner

Bullock D Fraser

Disclosed activity across 2 companies

Tapewire entity
138285
SEC CIK
0001366853

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Health Catalyst, Inc.HCAT · Entity 1565DirectorJune 10, 2021June 14, 2021
Huckleberry.ai, Inc.DOMO · Entity 6423DirectorJune 04, 2019June 24, 2020

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Health Catalyst, Inc.

Report date June 10, 2021 · Filed June 14, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect44,999 Reported balance After 2021-06-10 transaction · row 1
1 source row

Row 1 · 2021-06-10 · Grant · Acquired 3,285 · Balance 44,999

F1: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) June 10, 2022 and (ii) the date of the next Annual Meeting of the Issuer's Stockholders.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) June 10, 2022 and (ii) the date of the next Annual Meeting of the Issuer's Stockholders.

Huckleberry.ai, Inc.

Report date June 04, 2019 · Filed June 24, 2020 · Amendment

Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class B Common StockSEC Table I · non-derivativeDirect20,784 Reported balance Holding disclosure · report date 2019-06-04 · row 1 Amendment: may correct only part of an earlier disclosure.
1 source row

Row 1 · Balance 20,784

F1: On June 6, 2019, a Form 4 was mistakenly filed on behalf of the Reporting Person, reporting an award of 4,699 Restricted Stock Units. As of June 6, 2019, the Reporting Person directly held only 20,784 shares of Class B Common Stock of the Issuer.

F2: Includes 783 shares of Class B Common Stock acquired as a zero-cost, pro rata distribution from Zetta Venture Partners I, L.P.

Class B Common StockSEC Table I · non-derivativeIndirectSee footnote97,762 Reported balance Holding disclosure · report date 2019-06-04 · row 2 Amendment: may correct only part of an earlier disclosure.
1 source row

Row 2 · Balance 97,762

F3: The reported securities are held directly by the Bullock Family 101 Trust. Robert Gardner serves as trustee to the Bullock Family 101 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 101 Trust except to the extent of any pecuniary interest therein.

Class B Common StockSEC Table I · non-derivativeIndirectSee footnote8,666 Reported balance Holding disclosure · report date 2019-06-04 · row 3 Amendment: may correct only part of an earlier disclosure.
1 source row

Row 3 · Balance 8,666

F4: The reported securities are held directly by the Bullock Family 2003 Gift Trust. Jennifer Bullock serves as trustee to the Bullock Family 2003 Gift Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 2003 Gift Trust except to the extent of any pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: On June 6, 2019, a Form 4 was mistakenly filed on behalf of the Reporting Person, reporting an award of 4,699 Restricted Stock Units. As of June 6, 2019, the Reporting Person directly held only 20,784 shares of Class B Common Stock of the Issuer.

F2: Includes 783 shares of Class B Common Stock acquired as a zero-cost, pro rata distribution from Zetta Venture Partners I, L.P.

F3: The reported securities are held directly by the Bullock Family 101 Trust. Robert Gardner serves as trustee to the Bullock Family 101 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 101 Trust except to the extent of any pecuniary interest therein.

F4: The reported securities are held directly by the Bullock Family 2003 Gift Trust. Jennifer Bullock serves as trustee to the Bullock Family 2003 Gift Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 2003 Gift Trust except to the extent of any pecuniary interest therein.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 10, 2021 Filed Jun 14, 2021 16:56 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 3,285 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-004244 · primarydocument.xml · nonDerivative · entry 1

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,999

F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) June 10, 2022 and (ii) the date of the next Annual Meeting of the Issuer's Stockholders.

Read SEC document
December 04, 2020 Filed Dec 8, 2020 16:51 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 25,777 $37.19 $958,551.26
Disclosure

SEC source: 0001562180-20-007110 · primarydocument.xml · nonDerivative · entry 1

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,714

F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 12, 2019, in accordance with Rule 10b5-1.

F2 · price: Represents the weighted average sale price of the shares sold ranging from $37.00 to $37.44 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 02, 2020 Filed Oct 7, 2020 18:51 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 1,700 $37.01 $62,917.00
Disclosure

SEC source: 0001562180-20-006319 · primarydocument.xml · nonDerivative · entry 1

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,491

F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 12, 2019, in accordance with Rule 10b5-1.

F2 · price: Represents the weighted average sale price of the shares sold ranging from $37.00 to $37.03 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 01, 2020 Filed Oct 2, 2020 16:53 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 423 $37.00 $15,651.63
Disclosure

SEC source: 0001562180-20-006234 · primarydocument.xml · nonDerivative · entry 1

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,191

F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 12, 2019, in accordance with Rule 10b5-1.

F2 · price: Represents the weighted average sale price of the shares sold ranging from $37.00 to $37.01 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 28, 2020 Filed Jul 29, 2020 17:33 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 400 $37.00 $14,800.00
Disclosure

SEC source: 0001562180-20-005227 · primarydocument.xml · nonDerivative · entry 2

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,614

F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 12, 2019, in accordance with Rule 10b5-1.

Read SEC document
July 27, 2020 Filed Jul 29, 2020 17:33 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 1,700 $37.01 $62,923.97
Disclosure

SEC source: 0001562180-20-005227 · primarydocument.xml · nonDerivative · entry 1

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,014

F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 12, 2019, in accordance with Rule 10b5-1.

F2 · price: Represents the weighted average sale price of the shares sold ranging from $37.00 to $37.02 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 12, 2020 Filed Jun 17, 2020 19:20 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 5,443 $0.00 $0.00
Disclosure

SEC source: 0001562180-20-004565 · primarydocument.xml · nonDerivative · entry 1

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,714

F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the date of the next Annual Meeting of the Issuer's Stockholders.

Read SEC document
February 14, 2020 Filed Feb 20, 2020 19:05 UTC Health Catalyst, Inc. HCAT · Entity 1565 OtherCommon Stock 29,482 $0.00 $0.00
Disclosure

SEC source: 0001562180-20-001417 · primarydocument.xml · nonDerivative · entry 2

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,271

F1 · kind: Represents a pro rata distribution for no consideration.

Read SEC document
February 14, 2020 Filed Feb 20, 2020 19:05 UTC Health Catalyst, Inc. HCAT · Entity 1565 OtherCommon Stock 609,143 $0.00 $0.00
Disclosure

SEC source: 0001562180-20-001417 · primarydocument.xml · nonDerivative · entry 1

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

F1 · kind: Represents a pro rata distribution for no consideration.

F2 · ownership.nature: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of these shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein.

Read SEC document
February 05, 2020 Filed Feb 7, 2020 17:51 UTC Health Catalyst, Inc. HCAT · Entity 1565 OtherCommon Stock 33,232 $0.00 $0.00
Disclosure

SEC source: 0001562180-20-001027 · primarydocument.xml · nonDerivative · entry 2

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,789

F3 · kind: Shares acquired by the Reporting Person pursuant to pro rata distributions for no consideration.

Read SEC document
February 05, 2020 Filed Feb 7, 2020 17:51 UTC Health Catalyst, Inc. HCAT · Entity 1565 OtherCommon Stock 609,144 $0.00 $0.00
Disclosure

SEC source: 0001562180-20-001027 · primarydocument.xml · nonDerivative · entry 1

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 609,143

F1 · kind: Represents a pro rata distribution for no consideration.

F2 · ownership.nature: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein.

Read SEC document
September 01, 2019 Filed Sep 3, 2019 19:51 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 3,557 $0.00 $0.00
Disclosure

SEC source: 0001562180-19-004588 · primarydocument.xml · nonDerivative · entry 1

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,557

F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the date of the next Annual Meeting of the Issuer's Stockholders.

Read SEC document
July 29, 2019 Filed Jul 29, 2019 21:01 UTC Health Catalyst, Inc. HCAT · Entity 1565 ConversionSeries D Preferred Stock · Derivative 235,916 $0.00 $0.00
Disclosure

SEC source: 0001628280-19-009171 · wf-form4_156444845692930.xml · derivative · entry 6

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 235,916 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F4 · price: Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F4 · derivative.exercise_date: Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F4 · derivative.expiration_date: Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F2 · ownership.nature: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein.

Read SEC document
July 29, 2019 Filed Jul 29, 2019 21:01 UTC Health Catalyst, Inc. HCAT · Entity 1565 ConversionSeries C Preferred Stock · Derivative 345,591 $0.00 $0.00
Disclosure

SEC source: 0001628280-19-009171 · wf-form4_156444845692930.xml · derivative · entry 5

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 345,591 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F3 · price: Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F3 · derivative.exercise_date: Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F3 · derivative.expiration_date: Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F2 · ownership.nature: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein.

Read SEC document
July 29, 2019 Filed Jul 29, 2019 21:01 UTC Health Catalyst, Inc. HCAT · Entity 1565 ConversionSeries B Preferred Stock · Derivative 636,780 $0.00 $0.00
Disclosure

SEC source: 0001628280-19-009171 · wf-form4_156444845692930.xml · derivative · entry 4

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 636,780 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series B Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F1 · price: Each share of Series B Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F1 · derivative.exercise_date: Each share of Series B Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F1 · derivative.expiration_date: Each share of Series B Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F2 · ownership.nature: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein.

Read SEC document
July 29, 2019 Filed Jul 29, 2019 21:01 UTC Health Catalyst, Inc. HCAT · Entity 1565 ConversionCommon Stock 235,916 $0.00 $0.00
Disclosure

SEC source: 0001628280-19-009171 · wf-form4_156444845692930.xml · nonDerivative · entry 3

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,218,287

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F2 · ownership.nature: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein.

Read SEC document
July 29, 2019 Filed Jul 29, 2019 21:01 UTC Health Catalyst, Inc. HCAT · Entity 1565 ConversionCommon Stock 345,591 $0.00 $0.00
Disclosure

SEC source: 0001628280-19-009171 · wf-form4_156444845692930.xml · nonDerivative · entry 2

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 982,371

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F2 · ownership.nature: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein.

Read SEC document
July 29, 2019 Filed Jul 29, 2019 21:01 UTC Health Catalyst, Inc. HCAT · Entity 1565 ConversionCommon Stock 636,780 $0.00 $0.00
Disclosure

SEC source: 0001628280-19-009171 · wf-form4_156444845692930.xml · nonDerivative · entry 1

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 636,780

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series B Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

F2 · ownership.nature: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein.

Read SEC document
June 04, 2019 Filed Jun 6, 2019 21:34 UTC Huckleberry.ai, Inc. DOMO · Entity 6423 GrantClass B Common Stock 4,699 $0.00 $0.00
Disclosure

SEC source: 0001628280-19-007679 · wf-form4_155987125635584.xml · nonDerivative · entry 1

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,483

F1 · shares: The shares are represented by restricted stock units ("RSU"s). Each RSU represents the Reporting Person's right to receive one share of Class B Common Stock of the Issuer, subject to the applicable vesting schedule. In the event the Reporting Person ceases to be a service provider, the unvested RSUs will be cancelled by the issuer

F1 · price: The shares are represented by restricted stock units ("RSU"s). Each RSU represents the Reporting Person's right to receive one share of Class B Common Stock of the Issuer, subject to the applicable vesting schedule. In the event the Reporting Person ceases to be a service provider, the unvested RSUs will be cancelled by the issuer

F2 · balance_after: 783 shares acquired as a zero-cost, pro rata distribution from Zetta Venture Partners I, L.P.

Read SEC document
July 03, 2018 Filed Jul 3, 2018 20:18 UTC Huckleberry.ai, Inc. DOMO · Entity 6423 ConversionSeries C Preferred Stock · Derivative 70,190 $0.00 $0.00
Disclosure

SEC source: 0001628280-18-009098 · wf-form4_153066347844675.xml · derivative · entry 6

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Class B Common Stock · 70,190 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date.

F3 · derivative.exercise_date: Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date.

F3 · derivative.expiration_date: Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date.

F2 · ownership.nature: The reported securities are held directly by the Bullock Family 101 Trust. Robert Gardner serves as trustee to the Bullock Family 101 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 101 Trust except to the extent of any pecuniary interest therein.

Read SEC document
July 03, 2018 Filed Jul 3, 2018 20:18 UTC Huckleberry.ai, Inc. DOMO · Entity 6423 ConversionSeries A Preferred Stock · Derivative 18,783 $0.00 $0.00
Disclosure

SEC source: 0001628280-18-009098 · wf-form4_153066347844675.xml · derivative · entry 5

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Class B Common Stock · 18,783 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date.

F3 · derivative.exercise_date: Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date.

F3 · derivative.expiration_date: Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date.

F2 · ownership.nature: The reported securities are held directly by the Bullock Family 101 Trust. Robert Gardner serves as trustee to the Bullock Family 101 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 101 Trust except to the extent of any pecuniary interest therein.

Read SEC document
July 03, 2018 Filed Jul 3, 2018 20:18 UTC Huckleberry.ai, Inc. DOMO · Entity 6423 ConversionClass B Common Stock 70,190 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-18-009098 · wf-form4_153066347844675.xml · nonDerivative · entry 3

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 97,762

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The reported securities are held directly by the Bullock Family 2003 Gift Trust. Jennifer Bullock serves as trustee to the Bullock Family 2003 Gift Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 2003 Gift Trust except to the extent of any pecuniary interest therein.

F2 · ownership.nature: The reported securities are held directly by the Bullock Family 101 Trust. Robert Gardner serves as trustee to the Bullock Family 101 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 101 Trust except to the extent of any pecuniary interest therein.

Read SEC document
July 03, 2018 Filed Jul 3, 2018 20:18 UTC Huckleberry.ai, Inc. DOMO · Entity 6423 ConversionClass B Common Stock 18,783 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-18-009098 · wf-form4_153066347844675.xml · nonDerivative · entry 2

Bullock D Fraser · CIK 0001366853 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 27,572

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The reported securities are held directly by the Bullock Family 2003 Gift Trust. Jennifer Bullock serves as trustee to the Bullock Family 2003 Gift Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 2003 Gift Trust except to the extent of any pecuniary interest therein.

F2 · ownership.nature: The reported securities are held directly by the Bullock Family 101 Trust. Robert Gardner serves as trustee to the Bullock Family 101 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 101 Trust except to the extent of any pecuniary interest therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.